C. Wolf

Diagnostic utility of angiogenic biomarkers in pregnant women with suspected preeclampsia: A health economics review.

M. Vatish, M. Hund, D. Schlembach, 2019, Pregnancy hypertension.

sFlt-1/PlGF ratio for prediction of preeclampsia in clinical routine: A pragmatic real-world analysis of healthcare resource utilisation

H. Stepan, S. Verlohren, Anne Dathan-Stumpf, 2022, PloS one.

Economic evaluation of the sFlt-1/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study

A. Ohkuchi, H. Masuyama, S. Saito, 2021, Hypertension Research.

Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States.

J. Posnett, J. Espinoza, A. Mueller, 2021, Pregnancy hypertension.

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

M. Hund, D. Schlembach, A. Schroer, 2018, BMC Health Services Research.

sFlt‐1/PlGF ratio test for pre‐eclampsia: an economic assessment for the UK

M. Vatish, D. Allegranza, M. Hund, 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Real‐world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non‐valvular atrial fibrillation patients in England

M. Sculpher, H. Petri, F. Vahidnia, 2020, Journal of evaluation in clinical practice.

Economic evaluation of sFlt-1/PlGF ratio test in pre-eclampsia prediction and diagnosis in two Brazilian hospitals.

E. Cordioli, E. Zlotnik, C. Wolf, 2018, Pregnancy hypertension.